Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Unlabelled: Winter wheat must undergo vernalization to flower, while spring wheat does not require vernalization. The requirement for vernalization in wheat is primarily controlled by vernalization genes. are the most important vernalization genes. The recessive alleles have a strict vernalization requirement, while dominant mutations in eliminate or reduce this requirement. In this study, the near-isogenic lines for several allelic variants (, , , and ) were generated in two winter wheat backgrounds. Under field conditions, the four dominant allelic variants (, , , and ) resulted in an advancement in the heading date by 3-5 days. Using an artificially controlled gradient vernalization treatment (4-5 ℃, ranging from 0 to 45 days with 5-day intervals), the vernalization requirements of allelic variants were analyzed. The relative effects on vernalization requirements were found to be  >  =  >  =  (opposite to the heading date). Gene expression analysis indicates that the earlier heading associated with the dominant allelic variants is linked to their open expression under non-vernalization conditions. There may be an expression threshold at the locus that eliminates the vernalization requirement, and this threshold should be lower than the levels observed under saturated vernalization conditions. Furthermore, once this hypothesized threshold is reached, there appears to be no dosage effect on expression. These results deepen our understanding of wheat vernalization genes and provide a theoretical basis for utilizing these genes in breeding programs aimed at improving wheat adaptability.

Supplementary Information: The online version contains supplementary material available at 10.1007/s11032-025-01565-1.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11996741PMC
http://dx.doi.org/10.1007/s11032-025-01565-1DOI Listing

Publication Analysis

Top Keywords

allelic variants
20
vernalization
14
vernalization requirements
12
vernalization requirement
12
vernalization genes
12
wheat vernalization
8
winter wheat
8
dominant allelic
8
wheat
7
variants
5

Similar Publications

Background: Overexpression of rs3761936 of DCLRE1B gene has been observed in both breast cancer and cervical cancer patients. To justify the association of this polymorphism with these cancers, we performed this case-control study.

Method: A total of 245 cancer patients and 108 healthy controls participated in the research.

View Article and Find Full Text PDF

Purpose: To investigate the variants in 18 disease-causing genes associated with nonsyndromic myopia in 83 Chinese individuals diagnosed with early-onset high myopia(eo-HM).

Methods: Variants in 18 candidate genes in 83 probands with eo-HM were distinguished by whole-exome sequencing (WES) and assessed by multistep bioinformatics analysis.

Results: Four likely pathogenic variants were detected in 4 of the 83 probands (4.

View Article and Find Full Text PDF

Rheumatoid arthritis (RA) is a chronic autoimmune disease in which dysregulated interferon regulatory factor 5 (IRF5) may amplify pro-inflammatory pathways; prior genetic studies of IRF5 single-nucleotide variants (SNVs) in RA are inconsistent across populations and have not included mestizo Mexicans or evaluated rs59110799 in RA. We aimed to test whether four IRF5 SNVs (rs2004640G/T, rs2070197T/C, rs10954213G/A, rs59110799G/T) confer susceptibility to RA in women from Central Mexico. In a case-control study of 239 women with RA and 231 female controls (all self-identified Mexican-Mestizos, ≥3 generations), genotyping was performed by real-time PCR with TaqMan® probes; 80% of samples were duplicated (100% concordance) and control genotypes conformed to Hardy-Weinberg equilibrium.

View Article and Find Full Text PDF

Chronic myelomonocytic leukemia (CMML) is an aggressive hematologic neoplasm characterized by an expansion of CD123 monocytes and plasmacytoid dendritic cells (pDCs). pDC bone marrow clusters in CMML have been associated with higher rates of acute myeloid leukemia transformation. We evaluated tagraxofusp, a CD123-targeted therapy, in a phase 1/2 trial for patients with CMML.

View Article and Find Full Text PDF

Introduction: The COVID-19 pandemic had significant global public health consequences, affecting over 200 countries and regions by 2020. The development and efficacy of specific vaccines, such as the mRNA-1273 (Spikevax) vaccine developed by Moderna Inc., have substantially reduced the impact of the pandemic and mitigated its consequences.

View Article and Find Full Text PDF